Top

European Journal of Orthopaedic Surgery & Traumatology

Published in:

01-05-2019 | Knee-TEP | Original Article • KNEE - ARTHROPLASTY

Aspirin versus rivaroxaban in postoperative bleeding after total knee arthroplasty: a retrospective case-matched study

Authors: Varah Yuenyongviwat, Pakjai Tuntarattanapong, Chaiwat Chuaychoosakoon, Chavalit Iemsaengchairat, Khanin Iamthanaporn, Theerawit Hongnaparak

Published in: European Journal of Orthopaedic Surgery & Traumatology | Issue 4/2019

Abstract

Background

Venous thromboembolic disease (VTE) is a complication not uncommon following total knee arthroplasty. Postoperative bleeding-related complications are a concern in many guidelines. The authors aimed to compare the amount of postoperative drainage from closed suction drainage, transfusion rate, and postoperative complications between aspirin and rivaroxaban as VTE prophylaxes after total knee arthroplasty.

Methods

This study was a retrospective case-matched study of 155 patients. The data were collected between 2008 and 2015 from patients who had total knee arthroplasty using aspirin or rivaroxaban as the VTE prophylaxis. Seventy-nine patients received aspirin, and 76 patients received rivaroxaban. A single surgeon operated on all patients with the same surgical technique and patient care protocol.

Results

The total closed suction drainage outputs at 48 h were not significantly different between the aspirin and rivaroxaban groups (p = 0.10). Eighteen percent of patients in the aspirin group and 25% of patients in the rivaroxaban group received blood transfusions (p = 0.37). There were no bleeding-related complications or VTE in either group.

Conclusions

Aspirin and rivaroxaban were effective and safe as VTE chemoprophylaxis in total knee arthroplasty.

Leskinen J, Eskelinen A, Huhtala H, Paavolainen P, Remes V (2012) The incidence of knee arthroplasty for primary osteoarthritis grows rapidly among baby boomers: a population-based study in Finland. Arthritis Rheum 64(2):423–428CrossRefPubMed

Lee DK, Kim HJ, Lee DH (2016) Incidence of deep vein thrombosis and venous thromboembolism following TKA in rheumatoid arthritis versus osteoarthritis: a meta-analysis. PLoS ONE 11(12):e0166844CrossRefPubMedPubMedCentral

Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, Colin C, Ghali WA, Burnand B, IMECCHI Group (2012) Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 307(3):294–303CrossRefPubMed

Lachiewicz PF (2009) Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Orthopedics 32(12 Suppl):74–78CrossRefPubMed

Colwell CW (2009) The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty. Orthopedics 32(12 Suppl):67–73CrossRefPubMed

Nikolaou VS, Desy NM, Bergeron SG, Antoniou J (2011) Total knee replacement and chemical thromboprophylaxis: current evidence. Curr Vasc Pharmacol 9(1):33–41CrossRefPubMed

Budhiparama NC, Abdel MP, Ifran NN, Parratte S (2014) Venous thromboembolism (VTE) prophylaxis for hip and knee arthroplasty: changing trends. Curr Rev Musculoskelet Med 7(2):108–116CrossRefPubMedPubMedCentral

Mont MA, Jacobs JJ (2011) AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 19(12):777–778CrossRefPubMed

An VV, Phan K, Levy YD, Bruce WJ (2016) Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis. J Arthroplasty 31(11):2608–2616CrossRefPubMed

10.

Wilson DG, Poole WE, Chauhan SK, Rogers BA (2016) Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty. Bone Joint J 98-B(8):1056–1061CrossRefPubMed

11.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA (2013) Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin. Ann Vasc Surg 27(3):355–369CrossRefPubMed

12.

Anderson DR, Dunbar M, Murnaghan J, Kahn SR, Gross P, Forsythe M, Pelet S, Fisher W, Belzile E, Dolan S, Crowther M, Bohm E, MacDonald SJ, Gofton W, Kim P, Zukor D, Pleasance S, Andreou P, Doucette S, Theriault C, Abianui A, Carrier M, Kovacs MJ, Rodger MA, Coyle D, Wells PS, Vendittoli PA (2018) Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med 378(8):699–707CrossRefPubMed

13.

Jacobs JJ, Mont MA, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AC Jr, Boggio LN, Watters WC III, Turkelson CM, Wies JL, Sluka P, Hitchcock K (2012) American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am 94:746–747CrossRefPubMedPubMedCentral

14.

Mostafavi Tabatabaee R, Rasouli MR, Maltenfort MG, Parvizi J (2015) Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin. J Arthroplasty 30(2):159–164CrossRefPubMed

15.

Atkins RM (2010) NICE and venous thromboembolism. J Bone Joint Surg Br 92(5):609–610CrossRefPubMed

16.

Lieberman JR, Pensak MJ (2013) Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 95(19):1801–1811CrossRef

17.

Colleoni JL, Ribeiro FN, Mos PAC, Reis JP, Oliveira HR, Miura BK (2017) Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban. Rev Bras Ortop 53(1):22–27CrossRefPubMedPubMedCentral

18.

Bala A, Huddleston JI 3rd, Goodman SB, Maloney WJ, Amanatullah DF (2017) Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors? Clin Orthop Relat Res 475(9):2205–2213CrossRefPubMedPubMedCentral

19.

Zou Y, Tian S, Wang Y, Sun K (2014) Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis 25(7):660–664CrossRefPubMed

Title: Aspirin versus rivaroxaban in postoperative bleeding after total knee arthroplasty: a retrospective case-matched study
Authors: Varah Yuenyongviwat
Pakjai Tuntarattanapong
Chaiwat Chuaychoosakoon
Chavalit Iemsaengchairat
Khanin Iamthanaporn
Theerawit Hongnaparak
Publication date: 01-05-2019
Publisher: Springer Paris
Keywords: Knee-TEP
Knee-TEP
Rivaroxaban
Published in: European Journal of Orthopaedic Surgery & Traumatology / Issue 4/2019
Print ISSN: 1633-8065
Electronic ISSN: 1432-1068
DOI: https://doi.org/10.1007/s00590-019-02365-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Aspirin versus rivaroxaban in postoperative bleeding after total knee arthroplasty: a retrospective case-matched study

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2019

The use of tourniquet may influence the cement mantle thickness under the tibial implant during total knee arthroplasty

A new radiographic acetabular cup anteversion measurement method in total hip arthroplasty: a clinical study

Patient-dependent risk factors for self-perceived leg length discrepancy after total hip arthroplasty

Outcomes of posterior cruciate ligament tibial avulsion treated with staple fixation: stress TELOS X-ray evaluation

Hemiarthroplasty for neck of femur fractures: to cement or not? A systematic review of literature and meta-analysis

Mid-term clinical results of the cementless R3 cup and Polarstem total hip arthroplasty